bluebird bio Inc. (BLUE)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
bluebird bio Statistics
Share Statistics
bluebird bio has 9.72M shares outstanding. The number of shares has increased by -94.96% in one year.
Shares Outstanding | 9.72M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -94.99% |
Owned by Institutions (%) | n/a |
Shares Floating | 9.64M |
Failed to Deliver (FTD) Shares | 12.30K |
FTD / Avg. Volume | 2.97% |
Short Selling Information
The latest short interest is 47.71M, so 490.69% of the outstanding shares have been sold short.
Short Interest | 47.71M |
Short % of Shares Out | 490.69% |
Short % of Float | 495.05% |
Short Ratio (days to cover) | 9.53 |
Valuation Ratios
The PE ratio is -14.3 and the forward PE ratio is -0.6.
PE Ratio | -14.3 |
Forward PE | -0.6 |
PS Ratio | 102.76 |
Forward PS | 0.2 |
PB Ratio | 15.58 |
P/FCF Ratio | -12.42 |
PEG Ratio | n/a |
Enterprise Valuation
bluebird bio Inc. has an Enterprise Value (EV) of 712.19M.
EV / Earnings | -3.36 |
EV / Sales | 24.14 |
EV / EBITDA | -4.26 |
EV / EBIT | -2.92 |
EV / FCF | -2.92 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.7.
Current Ratio | 1.41 |
Quick Ratio | 1.29 |
Debt / Equity | 1.7 |
Total Debt / Capitalization | 62.94 |
Cash Flow / Debt | -0.71 |
Interest Coverage | -14.94 |
Financial Efficiency
Return on equity (ROE) is -1.09% and return on capital (ROIC) is -46.51%.
Return on Equity (ROE) | -1.09% |
Return on Assets (ROA) | -0.34% |
Return on Capital (ROIC) | -46.51% |
Revenue Per Employee | 78.66K |
Profits Per Employee | -565.10K |
Employee Count | 375 |
Asset Turnover | 0.05 |
Inventory Turnover | 1.46 |
Taxes
Income Tax | -126.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -63.13% in the last 52 weeks. The beta is 0.8, so bluebird bio 's price volatility has been higher than the market average.
Beta | 0.8 |
52-Week Price Change | -63.13% |
50-Day Moving Average | 8.11 |
200-Day Moving Average | 14.5 |
Relative Strength Index (RSI) | 45.77 |
Average Volume (20 Days) | 414.02K |
Income Statement
In the last 12 months, bluebird bio had revenue of 29.50M and earned -211.91M in profits. Earnings per share was -1.93.
Revenue | 29.50M |
Gross Profit | -4.03M |
Operating Income | -244.26M |
Net Income | -211.91M |
EBITDA | -167.16M |
EBIT | -244.26M |
Earnings Per Share (EPS) | -1.93 |
Balance Sheet
The company has 221.75M in cash and 330.33M in debt, giving a net cash position of -108.57M.
Cash & Cash Equivalents | 221.75M |
Total Debt | 330.33M |
Net Cash | -108.57M |
Retained Earnings | -4.26B |
Total Assets | 465.06M |
Working Capital | -145.22M |
Cash Flow
In the last 12 months, operating cash flow was -235.05M and capital expenditures -9.06M, giving a free cash flow of -244.10M.
Operating Cash Flow | -235.05M |
Capital Expenditures | -9.06M |
Free Cash Flow | -244.10M |
FCF Per Share | -2.22 |
Margins
Gross margin is -13.66%, with operating and profit margins of -828.09% and -718.42%.
Gross Margin | -13.66% |
Operating Margin | -828.09% |
Pretax Margin | -718.85% |
Profit Margin | -718.42% |
EBITDA Margin | -566.71% |
EBIT Margin | -828.09% |
FCF Margin | -827.55% |
Dividends & Yields
BLUE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -24.46% |
FCF Yield | -318.22% |
Analyst Forecast
The average price target for BLUE is $36.8, which is 366.4% higher than the current price. The consensus rating is "Hold".
Price Target | $36.8 |
Price Target Difference | 366.4% |
Analyst Consensus | Hold |
Analyst Count | 9 |
Stock Splits
The last stock split was on Dec 13, 2024. It was a backward split with a ratio of 1:20.
Last Split Date | Dec 13, 2024 |
Split Type | backward |
Split Ratio | 1:20 |
Scores
Altman Z-Score | -15.05 |
Piotroski F-Score | 2 |